Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 24, 1997

View Archived Issues

Merck KGaA claims new Na+/H+-exchange inhibitors

Protein farnesyltransferase inhibitors prepared at Schering-Plough

Gedeon Richter discloses agents for neurodegenerative disorders

More new taxoids from Rhone-Poulenc Rorer

Study results of Crinone as ART treatment presented

Lilly presents structurally novel thrombin inhibitors

BioChem Therapeutic synthesizes antiangiogenic fumagillin analogues

MainGen Biotechnologie formation announced

Bristol-Myers Squibb and Genome Therapeutics sign database license agreement

FDA clears SKB's ReQuip

Micrologix Biotech and BCCA expand research for anticancer agents

p53 phase II trial for head and neck cancer

RenaGel safely and effectively binds phosphate in volunteers

Micro Therapeutics awarded patent for stroke treatment; reports preliminary clinical results

Duramycin available for licensing from MoliChem Medicines

Novel iron complex available for licensing from MoliChem Medicines

AEterna initiates phase I trial in AMD

VasoCare reduces stress in animal model of hypertension

Anti-IgE MAb progresses to late-stage clinical trials in asthma

Sparta receives SBIR grant from NINDS

Lisofylline collaboration expanded to include AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...